Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Toronto skyline

Canada’s biotech challenge

July 27, 2009 Research and Development Canada, Transition Therapeutics, biotech, funding

 The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …
Feature

Sanofi buys Indian vaccines firm

July 27, 2009 Research and Development, Sales and Marketing Asia, Sanofi-Aventis, vaccines

News

AAIPharma sells development services unit

July 27, 2009 Manufacturing and Production, Research and Development AAI Pharma

US pharmaceutical services firm AAIPharma has sold its drug development division to a private equity firm in another example of …
News

BMS buys Medarex for $2.1 billion

July 24, 2009 Research and Development, Sales and Marketing BMS, MA, Medarex

Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …
News

Lupus drug shows surprise phase III success

July 23, 2009 Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …
News

Effient ‘unlikely’ to takeover from Plavix

July 23, 2009 Research and Development, Sales and Marketing Effient, cv

News

Kennedy calls for overhaul of NICE processes

July 23, 2009 Research and Development, Sales and Marketing NICE, hta

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …
News

NICE approves MabThera for leukaemia

July 22, 2009 Research and Development, Sales and Marketing MabThera, NICE

NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …
News

Phase Forward buys Covance unit for $10m

July 21, 2009 Research and Development CRO, Phase Forward

US clinical data management specialist Phase Forward is planning to get bigger in interactive response technologies (IRT) via a $10 …
News

Roche eyes expanded colon cancer label for Xeloda

July 20, 2009 Research and Development, Sales and Marketing Roche, Xeloda

Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …
News

Jubilant makes solid start to fiscal 2010

July 20, 2009 Manufacturing and Production, Research and Development Jubilant

Indian contract research and manufacturing services company Jubilant Organosys shrugged off the effects of the economic downturn with a buoyant …
News

Drug repositioning a ‘key strategy’ for pharma

July 17, 2009 Research and Development Datamonitor, strategy

With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …
News

Merck signs anticoagulant collaboration

July 17, 2009 Research and Development, Sales and Marketing Merck, cv

Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …
News

Effient approved in US

July 17, 2009 Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly

Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …
News

NICE bypassed in radical innovation boost

July 16, 2009 Research and Development, Sales and Marketing ABPI, Blueprint, NICE, hta

Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025